Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 10—October 2011
Perspective

Global Spread of Carbapenemase-producing Enterobacteriaceae

Patrice NordmannComments to Author , Thierry Naas, and Laurent Poirel

Author affiliation: Bicêtre Hospital, Le Kremlin-Bicêtre, France

Main Article

Table 2

Breakpoint values (MIC, mg/L) for carbapenems according to guidelines in Europe (EUCAST) and the United States (CLSI), September 2010*

Carbapenem EUCAST
CLSI
S R S R
Ertapenem <0.5 >1 <0.25 >1
Imipenem <2 >8 <1 >4
Meropenem <2 >8 <1 >4

*EUCAST, European Committee on Antimicrobial Susceptibility Testing (www.eucast.org/clinical_breakpoints); CLSI, Clinical and Laboratory Standards Institute; S, sensitive; R, resistant.

*EUCAST, European Committee on Antimicrobial Susceptibility Testing (www.eucast.org/clinical_breakpoints); CLSI, Clinical and Laboratory Standards Institute; S, sensitive; R, resistant.

*EUCAST, European Committee on Antimicrobial Susceptibility Testing (www.eucast.org/clinical_breakpoints); CLSI, Clinical and Laboratory Standards Institute; S, sensitive; R, resistant.

Main Article

Page created: September 19, 2011
Page updated: September 19, 2011
Page reviewed: September 19, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external